Archive for December, 2006

Introgen Announces New Clinical Data Confirming ADVEXIN(R … - netPR.pl (komunikaty prasowe)

Introgen Announces New Clinical Data Confirming ADVEXIN(R …netPR.pl (komunikaty prasowe), Poland - Dec 11, 2006The application will be for the use of ADVEXIN p53 therapy for the treatment of Li-Fraumeni Syndrome (LFS). LFS is a genetic disorder characterized by …

Read full story

Comments

Introgen Announces New Clinical Data Confirming ADVEXIN(R … - Earthtimes.org

Introgen Announces New Clinical Data Confirming ADVEXIN(R …Earthtimes.org - Dec 11, 2006Theapplication will be for the use of ADVEXIN p53 therapy for the treatment ofLi-Fraumeni Syndrome (LFS). LFS is a genetic disorder characterized …

Read full story

Comments

Introgen Announces New Clinical Data Confirming ADVEXIN(R) … - Medical News Today (press release)

Introgen Announces New Clinical Data Confirming ADVEXIN(R) …Medical News Today (press release), UK - Dec 12, 2006… for treatment of head and neck cancer and reinforces its Exceptional Circumstances Approval application in Europe for treatment of Li-Fraumeni Syndrome. …

Read full story

Comments

Preimplantation Genetic Diagnosis for Cancer Syndromes A New … - Journal of American Medical Association (subscription)

Preimplantation Genetic Diagnosis for Cancer Syndromes A New …Journal of American Medical Association (subscription), IL - 2 hours agoFor childhood-onset syndromes such as Li-Fraumeni syndrome, familial polyposis, or hereditary retinoblastoma, associated malignancies occur at a very early …

Read full story

Comments

Introgen Announces New Clinical Data Confirming ADVEXIN(R … - Medical News Today (press release)

Introgen Announces New Clinical Data Confirming ADVEXIN(R …Medical News Today (press release), UK - 17 hours agoThe application will be for the use of ADVEXIN p53 therapy for the treatment of Li-Fraumeni Syndrome (LFS). LFS is a genetic disorder characterized by …

Read full story

Comments

Introgen Announces New Clinical Data Confirming ADVEXIN(R) … - Yahoo! News (press release)

Introgen Announces New Clinical Data Confirming ADVEXIN(R) …Yahoo! News (press release) - 5 hours ago… for treatment of head and neck cancer and reinforces its Exceptional Circumstances Approval application in Europe for treatment of Li-Fraumeni Syndrome. … Introgen Announces New Clinical Data Confirming ADVEXIN(R) … Earthtimes.orgall 8 news articles

Read full story

Comments